Manufacturing & Bioprocessing - software & AI news

Daily news on software, AI, and companies shaping manufacturing & bioprocessing.

Showing 98 results
A minimalist representation of a virus-removal filter in a laboratory setting.

Sep 18, 2026

Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop Virus-Filtration System

Asahi Kasei Bioprocess is set to launch its innovative VANTIJ® SU-VFC benchtop virus-filtration system at the upcoming Bioprocess International (BPI) East event in Boston. This system is tailored for laboratory-scale applications and aims to enhance automation in virus filtration processes.The VANTIJ® SU-VFC is the inaugural benchtop model in Asahi Kasei's VANTIJ series, designed to streamline virus filtration while prioritizing user experience. It supports workflows utilizing 0.12 m² or 0.3 m²
A protein sample in a glass vial on a lab bench with spectroscopy equipment in the background.

Sep 18, 2026

Model-Free, Pure Component Analysis Could Help Biopharma Cut Costs

A new model-free approach to spectroscopy could significantly reduce costs in biopharmaceutical manufacturing by streamlining protein analysis.Traditional spectroscopic techniques, such as near-infrared (NIR) and Raman spectroscopy, rely heavily on empirical models to filter signals from background noise. These models are resource-intensive to develop, demanding extensive experimentation to cover all potential conditions. Bryan Hassell, CEO of Nirrin Technologies, emphasized that these models ar
A minimalist illustration of a bioprocessing tank in a dark palette.

Sep 17, 2026

Sartorius and NIBRT Partner on Intensified and Continuous Bioprocessing Training Center

Sartorius has announced a partnership with the National Institute for Bioprocessing Research and Training (NIBRT) to establish a new training center focused on intensified and continuous bioprocessing in Dublin, set to open in late 2026. This initiative aims to facilitate the biopharmaceutical sector's transition towards more efficient manufacturing practices.The training center will be equipped with Sartorius' Pionic technology, which provides a comprehensive platform for continuous bioprocessi
A cell culture flask in a dimly lit lab setting, symbolizing cell therapy production.

Sep 16, 2026

Ori locks down $120M pact to deploy automated production platform for unnamed, commercial cell therapy

Ori Biotech has announced a significant 10-year partnership with an undisclosed biopharma firm, projected to generate $120 million through the integration of its Iro platform in the manufacturing of a commercial-stage cell therapy.This collaboration emphasizes Ori's innovative Iro technology, which combines hardware, software, and analytics to automate cell and gene therapy production. The platform, introduced in May 2024, has already gained recognition with an Advanced Manufacturing Technology
Press release cover image

Sep 15, 2026

Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop to Improve Efficiency and Consistency in Gene Therapy Manufacturing

GLENVIEW, Ill.--(BUSINESS WIRE)--Asahi Kasei Bioprocess, a subsidiary of diversified global company Asahi Kasei, will unveil the VANTIJ® SU-VFC Benchtop at Bioprocess International East (BPI EAST) 2026. This new VANTIJ® SU-VFC is a small-format system designed to deliver automated, single-use virus filtration for laboratory-scale and process development applications. The system will be available on site at Booth 606.The VANTIJ® SU-VFC Benchtop is the first benchtop-scale platform in Asahi Kasei
Press release cover image

Sep 14, 2026

Asimov Announces Cell Line Development Partnership with Sidewinder Therapeutics to Advance 4-Chain Bispecific Antibody for Solid Tumors

BOSTON, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Asimov, the company building an AI-native synthetic biology platform to advance therapeutic development, today announced a cell line development partnership with Sidewinder Therapeutics, a biopharmaceutical company pioneering the development of next-generation bispecific ADCs (antibody-drug conjugates) for the treatment of cancer. As part of a broader collaboration across multiple products, Asimov successfully delivered a cell line for Sidewinder’s bi
A minimalist illustration of a cell and an analyzer device in a lab setting.

Sep 14, 2026

Vi-CELL BLU 2.0 software boosts GMP readiness

Beckman Coulter Life Sciences has introduced the Vi-CELL BLU 2.0 Viability Analyzer Software, a significant upgrade designed to enhance cell viability workflows while ensuring compliance and data integrity.This new software version aims to facilitate the transition from research to biomanufacturing by providing laboratories with advanced cell analysis tools. It builds upon the existing Vi-CELL BLU instrument, featuring improved algorithms for cell counting and customizable analysis settings that
A sophisticated sensor on a bioreactor in a dimly lit laboratory

Sep 2, 2026

Regulatory Demands for More Process Control Data Fueling Innovation

Recent research highlights how regulatory expectations are driving innovation in continuous biomanufacturing processes, emphasizing the need for enhanced process control data.Korean researchers have identified that the evolution of process control in continuous manufacturing is significantly influenced by technological advancements and regulatory demands. Their findings point to a convergence of innovations that make continuous biomanufacturing increasingly feasible. Notably, advancements in pro
A vial of RNA on a lab bench with scientific equipment in the background.

Sep 2, 2026

US puts $125m into personalised RNA therapy production

The US Advanced Research Projects Agency for Health (ARPA-H) has allocated $125 million to enhance the production of customized RNA therapies through the Genetic Medicines and Individualised Manufacturing for Everyone (GIVE) initiative.This funding aims to transition from a traditional, centralized manufacturing model to a more efficient system designed for rapid production and accessibility. The GIVE program is expected to improve the availability of innovative treatments for various health con
Press release cover image

Aug 20, 2026

inFlow Inventory launches lot number and expiry date tracking

Small manufacturers and distributors in food, beverage, pharmaceutical and medical device industries can now trace any batch from receipt to customer, at a fraction of the cost of an enterprise ERP. TORONTO, Aug. 20, 2026 /PRNewswire/ -- inFlow Inventory has launched lot number and expiry date tracking, giving small and midsize manufacturers and distributors full batch-level traceability across purchasing, production, sales and shipping.This feature release follows two years of development and
A bioreactor in a dimly lit laboratory during blue hour, reflecting soft ambient light.

Aug 18, 2026

Copenhagen-based Again acquires US Geno to connect AI-driven discovery with industrial biomanufacturing

Copenhagen-based Again has acquired Genomatica, aiming to enhance the integration of AI-driven discovery with industrial biomanufacturing processes. This acquisition underscores a significant trend in the industrial biotech sector, where the focus is shifting from merely designing molecules to effectively engineering biological production systems.Again seeks to bridge the gap between discovering biological pathways and scaling them for economic viability in industrial settings. By incorporating
Affinity chromatography column in a biomanufacturing lab

Aug 17, 2026

Roundup: Removing Impurities from Biomanufacturing

Recent insights into impurity control in biomanufacturing highlight the importance of advanced technologies and strategic approaches for ensuring product quality and patient safety.Effective impurity management is essential in biomanufacturing, as it directly impacts the stability and efficacy of biotherapeutics. Leading companies emphasize the need for integrated separation and analytical techniques across both upstream and downstream processes. Techniques such as affinity chromatography are fo